| Line Item | 2026-03-27 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $100.0M | -10.3% | -11.2% |
| Cost of Revenue | $70.7M | -6.2% | -3.6% |
| Gross Profit | $29.3M | -18.9% | -25.5% |
| R&D Expense | $7.7M | +19.5% | -0.6% |
| SG&A Expense | $20.4M | -9.0% | -7.9% |
| Operating Income | $939K | -87.1% | -89.9% |
| Pre-tax Income | -$2.3M | -128.4% | -149.5% |
| Income Tax | -$244K | -110.1% | -121.4% |
| Net Income | -$2.1M | -136.1% | -158.5% |
| EPS (Basic) | -$0.16 | -136.4% | -157.1% |
| EPS (Diluted) | -$0.16 | -136.4% | -159.3% |
| Line Item | 2026-03-27 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $78.1M | -9.6% | +58.1% |
| Accounts Receivable | $187.6M | -7.6% | +5.4% |
| Current Assets | $450.4M | -8.8% | -1.4% |
| Total Assets | $616.5M | -6.5% | -1.9% |
| Current Liabilities | $226.3M | -15.3% | -19.8% |
| Long-term Debt | $104.3M |
| Line Item | 2026-03-27 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $10.5M | — | — |
| Capital Expenditures | $6.9M | — | — |
| Investing Cash Flow | -$7.8M | — | — |
| Financing Cash Flow | $15.8M | — | — |
| Free Cash Flow | $3.6M | — | — |
| +41.0% |
| Total Liabilities | $344.8M | -11.1% | -7.4% |
| Stockholders' Equity | $271.8M | +0.1% | +6.1% |